DEAE-Dextran 500 is a polycationic derivative of dextran, produced from dextran with an average molecular weight >500,000 Da. DEAE-Dextran 500 has a broad variety of applications including medicinal products, technical and chromatographic applications and as a polycationic stabilizing molecule.
DEAE-Dextran 500 is supplied in its HCI form.
This product page is for the technical product, for a GMP version please refer to DEAE-Dextran 500 Pharmaceutical Quality.
DEAE-Dextran 500
Batch Release Certificate
UK Version
IT Version
DK Version
Product Sheet
DEAE-Dextrans from Pharmacosmos are packed and stored in safe and clean conditions.
DEAE-Dextran 500 is available in the following pack sizes:
Item no | Weight | Packaging |
7506 0500 9003 | 5 g | 50 mL polyethylene (HDPE) container with a desiccant integrated in the LDPE cap and with tamper proof closure. |
7506 0500 9000 | 100 g | 500 mL wide neck, polyethylene (HDPE) container with tamper proof closure |
7506 0500 9000 |
500 g | 1500 mL wide neck, polyethylene (HDPE) container with tamper proof closure |
7506 0500 9000 |
5 kg | Polypropylene container. Dextran powder sealed in double polyethylene bags |
7506 0500 9000 |
50 kg | Fiber drum with the dextran powder sealed in double polyethylene bags and alu bag. |
DEAE-Dextran, being a polycation, offers many applications, such as a component/adjuvant in vaccines, for transfection and gene therapy, cholesterol/weight modulation, a stabiliser of proteins, in drug delivery and as a flocculant.
Please enter the
Pharmacosmos is the only dextran manufacturer holding certificates from the US FDA and European Directorate for the Quality of Medicines (EDQM)
Pharmacosmos delivers a unique dextran quality through a production technology that completely avoids the use of organic solvents and a quality system that meets the strictest cGMP standards for human medicines
Pharmacosmos sells and ships directly to clients everywhere in the World. We deliver Pharmaceutical Quality Dextran of the highest standards, including those of the European Pharmacopoeia (EP), the United States Pharmacopoeia (USP), and the Japanese Pharmacopoeia (JP).